QBTS Q1 2026 Earnings Narrowed Loss Beats Estimates Shares Surge Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress Precipio Q2 2025 Earnings Company Reports Positive EPS of 005 Stock Declines 309 BeyondSpring Q1 2026 Earnings Narrowing Loss Highlights Pipeline Progress Amid Zero Revenue Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss